EGFR mutational status in penile cancer

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 5, 2013, Pages 501-505

  Di Lorenzo, Giuseppe ^a   Buonerba, Carlo ^a   Gaudioso, Gabriella ^b   Gigantino, Vincenzo ^b   Quarto, Giuseppe ^b   De Domenico, Renato ^b   Caraglia, Michele ^c   Di Trolio, Rossella ^b   Ascierto, Paolo A ^b   De Placido, Sabino ^a   Perdonà, Sisto ^b   Franco, Renato ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Epidermal growth factor receptor expression; Epidermal growth factor receptor mutations; Immunohistochemistry; Penile cancer; Tissue micro array, target therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER STAGING; EXON; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOCAL EXCISION; PENIS AMPUTATION; PENIS CANCER; POINT MUTATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

HUMANS; MALE; MUTATION; PENILE NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS;

EID: 84876208927     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.783571     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29
2. Sonpavde G, Pagliaro LC, Buonerba C, et al. Penile cancer: current therapy and future directions. Ann Oncol 2013; Epub ahead of print
3. Verhoeven RH, Janssen-Heijnen ML, Saum KU, et al. Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 2012; Epub ahead of print
4. Di Lorenzo G, Buonerba C, Federico P, et al. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int 2012;110(11 Pt B):E661-6
5. Di Lorenzo G, Federico P, Buonerba C, et al. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol 2011;60:1280-4
6. Carthon BC, Pettaway C, Pagliaro LC. Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: updates and molecular analyses. J Clin Oncol 2010;28(Suppl):abstr e15022
7. Rescigno P, Matano E, Raimondo L, et al. Combination of docetaxel and cetuximab for penile cancer: a case report and literature review. Anticancer Drugs 2012;23:573-7
8. Necchi A, Nicolai N, Colecchia M, et al. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 2013;31:288-9
9. Lavens N, Gupta R, Wood LA. EGFR overexpression in squamous cell carcinoma of the penis. Curr Oncol 2010;17:4-6
10. Stankiewicz E, Prowse DM, Ng M, et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 2011;6:e17517
11. Saintigny P, Burger JA. Recent advances in non-small cell lung cancer biology and clinical management. Discov Med 2012;13:287-97
12. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-46
13. Seshacharyulu P, Ponnusamy MP, Haridas D, et al. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 2012;16:15-31
14. Shepherd FA, Rodrigues Pereira J, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32
15. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-6
16. Xu Y, Sheng L, Mao W. Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action. Oncol Lett 2013;5:19-24
17. Peereboom DM, Ahluwalia MS, Ye X, et al. NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiforme. Neuro Oncol 2013; Epub ahead of print
18. McMillen E, Ye F, Li G, et al. Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer. Exp Lung Res 2010;36:531-7
19. Andersson P, Kolaric A, Windahl T, et al. PIK3CA, HRAS and KRAS gene mutations in human penile cancer. J Urol 2008;179:2030-4